logo
16:01 Jan 20

Mercury Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
795.00
-5.00 (-0.63%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Mercury Laboratories Ltd. Financials

Mercury Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
795.00
-5.00 (-0.63%)
16:01 Jan 20
Quality
image/svg+xml

50/100
Medium Financial Strength

Valuation
image/svg+xml

49/100
Mid Valuation

Technical

32/100
Technically Bearish

Strength

6

Weakness

7

Opportunity

0

Threats

0

5.87 %

ROE %

4.23 %

ROA %

0.00

EPS

446.41

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
68.6 57.92 75.33 75.56 75.1
Operating Expenses +
59.01 50.81 66.77 66.53 68.08
Raw Material
31.01 23.88 30.96 30.45 29.66
Increase Decrease in Cost
0.16 -0.22 -0.55 -0.15 -0.74
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
9.8 12.37 14.23 14.5 16.84
Miscellaneous Expenses
21.1 18.88 26.91 26.45 26.74
Operating Profit
9.59 7.11 8.56 9.03 7.02
Other Income
0.88 0.82 1.72 1.09 1.07
Depreciation
1.92 2.45 2.48 2.82 2.88
Interest
0.64 0.45 0.36 0.38 0.55
Profit before tax and exceptio..
7.91 5.03 7.44 6.92 4.66
Exceptional Items
0 0.13 0.05 0 0
PBT
7.91 5.16 7.49 6.92 4.66
Provision for Taxation
2.57 1.47 1.91 1.27 1.52
Net Profit
5.34 3.69 5.58 5.65 3.14
NET Profit after MI
0 0 0 0 0
EPS
44.48 30.72 46.49 47.12 26.21
Operating Profit Margin (%)
13.98 12.28 11.36 11.95 9.35
Net Profit Margin (%)
7.78 6.37 7.41 7.48 4.18

Mercury Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 73.70 73.70 73.70 73.70 73.70 73.70
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 26.30 26.30 26.30 26.30 26.30 26.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: